• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

First-Time Generics - March 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 NOREPINEPHRINE BITARTRATE INJECTION, USP 1 MG (BASE)/ML, PACKAGED IN 4 MG (BASE)/4 ML SINGLE-DOSE VIALS GENSIA SICOR PHARMACEUTICALS, INC. LEVOPHED INJECTION 3/3/2003 
2 AMPHETAMINE AND DEXTROAMPHETAMINE (MIXED SALTS) TABLETS 7.5 MG (TOTAL), 12.5 MG (TOTAL), AND 15 MG (TOTAL) BARR PHARMACEUTICALS, INC. ADDERALL TABLETS 3/19/2003 
3 CARBINOXAMINE MALEATE TABLETS, USP 4 MG MIKART, INC. CLISTIN TABLETS 3/19/2003 
4 CEFADROXIL FOR ORAL SUSPENSION, USP 125 MG/5 ML, 250 MG/5 ML, AND 500 MG/5 ML RANBAXY LABORATORIES LIMITED DURACEF FOR ORAL SUSPENSION 3/26/2003 
5 ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS, USP 500 MG/30 MG ANDRX PHARMACEUTICALS, L.L.C. ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS U 3/27/2003 
6 ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS, USP 500 MG/60 MG ANDRX PHARMACEUTICALS L.LC. ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS 3/28/2003 
7 PROMETHAZINE HYDROCHLORIDE SUPPOSITORIES, USP 12.5 MG (NEW STRENGTH) G & W LABORATORIES, INC. PHENERGAN SUPPOSITORIES 3/31/2003 
8 IPRATROPIUM BROMIDE NASAL SOLUTION (NASAL SPRAY) 0.03% (0.021 MG/SPRAY) DEY, L.P. ATROVENT NASAL SPRAY 3/31/2003 
9 IPRATROPIUM BROMIDE NASAL SOLUTION, (NASAL SPRAY) 0.06% (0.042 MG/SPRAY) DEY, L.P. ATROVENT NASAL SPRAY 3/31/2003 

 

-
-